PSA President in new Senate
May 31, 2012
PROFESSOR Gabrielle Cooper, the
President of the Pharmaceutical
Society of Australia’s ACT Branch
has been appointed to the
Local Lead Clinicians Group -
otherwise known as the ACT
Clinical Senate.
The newly formed Senate is
designed to be a forum for health
experts and consumers to share
knowledge and discuss strategic
clinical issues, as well as to make
recommendations to improve
health outcomes of ACT residents.
The Senate will report to the
Director-General of the ACT
Government Health Directorate as
well as to the Chair of the ACT
Medicare Local, who will consider
and respond formally to the
Senate’s recommendations.
“It’s a great honour to be a
member of the Senate which will
provide advice on a wide range of
areas including clinical service
planning and reform, models of
care and service delivery,” said
Professor Cooper.
“I will be able to provide valuable
input on the role of pharmacists
and how they can improve patient
care through their full integration in
the provision of services to patients
across all settings of care.
“Further, our work will look at
major clinical strategic areas
including the development and
implementation of strategies to
implement national and territory
clinical guidelines and standards,”
she added.
The key issues that the Senate will
look to focus on, according to
Cooper, will revolve around
appropriate strategies to improve
the safety, quality, efficiency and
sustainability of clinical services
and prevention strategies.
“The ACT Clinical Senate is an
important step in the development
of a fully collaborative heath-care
system in the ACT,” she said.
The above article was sent to subscribers in Pharmacy Daily's issue from 31 May 12To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 31 May 12
